Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
October 08, 2019 02:44 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, October 8, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initiation of the first-in-human trial of MVA-BN® WEV, a prophylactic vaccine candidate against...
Bavarian Nordic indleder fase 1 forsøg med vaccine mod hesteencephalit virus
October 08, 2019 02:44 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. oktober 2019 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag påbegyndelsen af det første forsøg i mennesker med den forebyggende vaccinekandidat MVA-BN® WEV mod...
Bavarian Nordic fuldfører rekruttering til fase 2 forsøg i chordoma-kræft
October 03, 2019 02:09 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 3. oktober 2019 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at selskabet har fuldført rekrutteringen til fase 2-forsøget med kræftimmunterapikandidaten, BN-Brachyury...
Bavarian Nordic Completes Enrollment of Phase 2 Trial in Chordoma Patients
October 03, 2019 02:09 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, October 3, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the completion of enrollment of the Phase 2 trial investigating the novel targeted cancer...
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
September 24, 2019 13:45 ET
|
Bavarian Nordic A/S
First FDA approved non-replicating smallpox vaccineOnly FDA approved vaccine for prevention of monkeypoxCompany granted Priority Review VoucherConference call and webcast tomorrow at 3:00 PM CEST ...
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
September 24, 2019 13:45 ET
|
Bavarian Nordic A/S
First FDA approved non-replicating smallpox vaccineOnly FDA approved vaccine for prevention of monkeypoxCompany granted Priority Review VoucherConference call and webcast tomorrow at 3:00 PM CEST ...
Bavarian Nordic A/S - Vedtægter
August 29, 2019 04:05 ET
|
Bavarian Nordic A/S
Opdaterede vedtægter for Bavarian Nordic A/S
Vedhæftet fil
Bavarian Nordic - Vedtægter
...
Bavarian Nordic A/S - Articles of Association
August 29, 2019 04:05 ET
|
Bavarian Nordic A/S
Updated Articles of Association for Bavarian Nordic A/S
Attachment
Bavarian Nordic - Articles of Association
...
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
August 29, 2019 03:45 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 29. august 2019 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har forhøjet sin aktiekapital med nominelt DKK 685.000 som følge af medarbejderes udnyttelse af...
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
August 29, 2019 03:45 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, August 29, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 685,000 as a consequence of...